C87436 Inhibitors
Chemical inhibitors of the protein C87436 can exert their inhibitory effects via various intracellular signaling pathways. Alsterpaullone acts by inhibiting cyclin-dependent kinases, which are essential for cell cycle progression. In cells where C87436 function is cell cycle-dependent, the inhibition of these kinases by Alsterpaullone would result in a halt of the cell cycle, thereby impeding C87436 activity. Similarly, Wortmannin and LY294002, both phosphoinositide 3-kinases (PI3K) inhibitors, can prevent the activation of the PI3K/Akt signaling pathway. If C87436 operates downstream of or in conjunction with this pathway, the action of Wortmannin or LY294002 could lead to its functional inhibition by blocking necessary activation signals.
Other inhibitors target different aspects of cellular signaling. SB203580 and U0126, which inhibit p38 MAP kinase and MEK1/2 respectively, can disrupt the MAPK signaling pathway. If C87436's function is associated with this pathway, then these inhibitors can suppress its activity by interfering with the signaling cascade. SP600125 and PD98059, which inhibit the JNK and ERK/MAPK pathways, respectively, would similarly lead to the functional inhibition of C87436 if it is a part of these pathways. Triciribine, by specifically targeting Akt phosphorylation, can inhibit C87436 if it acts downstream of Akt. Dasatinib's inhibition of Src family kinases could also impact C87436 activity, assuming it is regulated by Src family kinases. Rapamycin inhibits mTOR, which could lead to the inhibition of C87436 if it is involved in mTOR-regulated processes. Lastly, Leflunomide and Thalidomide could indirectly inhibit C87436 by reducing pyrimidine synthesis and promoting protein degradation, respectively, if C87436 requires pyrimidine synthesis or is regulated by ubiquitination for its activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Alsterpaullone is a cyclin-dependent kinase inhibitor. By inhibiting CDKs, it can halt the cell cycle, thereby inhibiting the activity of C87436 if C87436's function is tied to cell cycle progression or regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K). If C87436 is involved in PI3K/Akt signaling, Wortmannin's inhibition of this pathway can lead to functional inhibition of C87436 by preventing its activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor. By inhibiting p38 MAPK, it can alter inflammatory responses and cellular stress pathways, inhibiting C87436 if C87436's activity is dependent on p38 MAPK signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor. It can prevent the activation of downstream targets of PI3K, leading to functional inhibition of C87436 if it is involved in the PI3K/Akt pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor, which prevents the activation of ERK/MAPK. If C87436's activity relies on ERK/MAPK signaling, then inhibition of this pathway can result in functional inhibition of C87436. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). Inhibition of JNK can lead to functional inhibition of C87436 if its activity is modulated by JNK signaling pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MEK1 and MEK2. By inhibiting these kinases, U0126 can inhibit ERK pathway activation, thus functionally inhibiting C87436 if it is a downstream effector in this pathway. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine specifically inhibits Akt phosphorylation and activation. If C87436 acts downstream of Akt, inhibition of Akt by Triciribine will result in the functional inhibition of C87436. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of cell growth and proliferation. If C87436 functions downstream of mTOR signaling, inhibition by Rapamycin could lead to functional inhibition of C87436. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a Src family kinase inhibitor. By inhibiting Src kinases, Dasatinib could functionally inhibit C87436 if C87436 is involved in signaling pathways that are regulated by Src family kinases. | ||||||